{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:42:07Z","timestamp":1791996127215,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50CA247749"],"award-info":[{"award-number":["P50CA247749"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ygyno.2024.12.009","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T11:49:16Z","timestamp":1734090556000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center"],"prefix":"10.1016","volume":"192","author":[{"given":"Ying L.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Praiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Devereaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Rizzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duaa","family":"Al-Rawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ygyno.2024.12.009_bb0005","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/bjc.2012.462","article-title":"Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing cross hospital, 2000-2009","volume":"107","author":"Sita-Lumsden","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.009_bb0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/GRF.0b013e31802f17fc","article-title":"Gestational trophoblastic disease","volume":"50","author":"Garner","year":"2007","journal-title":"Clin. Obstet. Gynecol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2024.12.009_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(03)90120-2","article-title":"Gestational trophoblastic neoplasia, FIGO 2000 staging and classification","volume":"83","author":"Ngan","year":"2003","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"9742","key":"10.1016\/j.ygyno.2024.12.009_bb0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ygyno.2024.12.009_bb0025","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1200\/JCO.2010.31.0151","article-title":"Treatment of low-risk gestational trophoblastic neoplasia","volume":"29","author":"Aghajanian","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.009_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2008.12.015","article-title":"Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia","volume":"105","author":"Oncology, F.C.o.G","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"6","key":"10.1016\/j.ygyno.2024.12.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.03.011","article-title":"Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity","volume":"200","author":"Chalouhi","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.12.009_bb0040","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","article-title":"EMA\/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients","volume":"15","author":"Bower","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.009_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2012.12.029","article-title":"Placental site trophoblastic tumor: analysis of presentation, treatment, and outcome","volume":"129","author":"Hyman","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.009_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2007.01.053","article-title":"Management and outcome of healthy women with a persistently elevated beta-hCG","volume":"106","author":"Palmieri","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"2 Pt 1","key":"10.1016\/j.ygyno.2024.12.009_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/AOG.0b013e31817f58ae","article-title":"Gestational trophoblastic neoplasia: treatment outcomes","volume":"112","author":"Hoekstra","year":"2008","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.009_bb0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ygyno.2009.02.006","article-title":"Impact of the revised FIGO\/WHO system on the management of patients with gestational trophoblastic neoplasia","volume":"113","author":"El-Helw","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2024.12.009_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"9","key":"10.1016\/j.ygyno.2024.12.009_bb0070","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/annonc\/mdn181","article-title":"Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel\/cisplatin alternating with paclitaxel\/etoposide (TP\/TE)","volume":"19","author":"Wang","year":"2008","journal-title":"Ann. Oncol."},{"issue":"5\u20136","key":"10.1016\/j.ygyno.2024.12.009_bb0075","first-page":"253","article-title":"30 years\u2019 experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary","volume":"55","author":"Fulop","year":"2010","journal-title":"J. Reprod. Med."},{"issue":"5\u20136","key":"10.1016\/j.ygyno.2024.12.009_bb0080","first-page":"238","article-title":"Treatment outcomes of gestational trophoblastic neoplasia in King Chulalongkorn Memorial Hospital over two decades","volume":"61","author":"Lertkhachonsuk","year":"2016","journal-title":"J. Reprod. Med."},{"issue":"7","key":"10.1016\/j.ygyno.2024.12.009_bb0085","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JCO.2010.30.4386","article-title":"Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study","volume":"29","author":"Osborne","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.009_bb0090","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ygyno.2012.03.003","article-title":"Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia","volume":"125","author":"Lybol","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.009_bb0095","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/AOG.0000000000001554","article-title":"Second curettage for low-risk nonmetastatic gestational trophoblastic neoplasia","volume":"128","author":"Osborne","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2024.12.009_bb0100","article-title":"First-line chemotherapy in low-risk gestational trophoblastic neoplasia","volume":"2016","author":"Lawrie","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.ygyno.2024.12.009_bb0105","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.2002.07.166","article-title":"Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000","volume":"20","author":"McNeish","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.009_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100110","article-title":"Increasing the human chorionic gonadotrophin cut-off to \u22641000 IU\/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy","volume":"6","author":"Cort\u00e9s-Charry","year":"2021","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.009_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100110","article-title":"Increasing the human chorionic gonadotrophin cut-off to <\/=1000 IU\/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy","volume":"6","author":"Cortes-Charry","year":"2021","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.ygyno.2024.12.009_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101169","article-title":"Etoposide, an anticancer drug involved in therapy-related secondary leukemia: enzymes at play","volume":"14","author":"Zhang","year":"2021","journal-title":"Transl. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.12.009_bb0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.2012.43.1817","article-title":"EMA\/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis","volume":"31","author":"Alifrangis","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2024.12.009_bb0130","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/1471-0528.16202","article-title":"Demographics, natural history and treatment outcomes of non-molar gestational choriocarcinoma: a UK population study","volume":"127","author":"Savage","year":"2020","journal-title":"Bjog"},{"issue":"2","key":"10.1016\/j.ygyno.2024.12.009_bb0135","article-title":"Choriocarcinoma after full-term pregnancy: a case report and review of the literature","volume":"14","author":"Katsanevakis","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ygyno.2024.12.009_bb0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.annpat.2014.02.009","article-title":"Incidental intraplacental gestational choriocarcinoma on a full-term placenta","volume":"34","author":"Sauvestre","year":"2014","journal-title":"Ann. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.009_bb0145","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ygyno.2019.03.011","article-title":"Placental site trophoblastic tumor and epithelioid trophoblastic tumor: clinical and pathological features, prognostic variables and treatment strategy","volume":"153","author":"Gadducci","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2024.12.009_bb0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41416-019-0402-0","article-title":"Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours","volume":"120","author":"Froeling","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.12.009_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-018-5168-x","article-title":"Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40years old: a systematic review and meta-analysis","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Cancer"},{"issue":"9683","key":"10.1016\/j.ygyno.2024.12.009_bb0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(09)60618-8","article-title":"Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study","volume":"374","author":"Schmid","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2024.12.009_bb0165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.humpath.2016.01.005","article-title":"Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics","volume":"52","author":"Aranake-Chrisinger","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2024.12.009_bb0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejca.2018.12.033","article-title":"The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia","volume":"109","author":"Frijstein","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2024.12.009_bb0175","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/IGC.0000000000000892","article-title":"PD-L1 expression in premalignant and malignant trophoblasts from gestational trophoblastic diseases is ubiquitous and independent of clinical outcomes","volume":"27","author":"Bolze","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"27","key":"10.1016\/j.ygyno.2024.12.009_bb0180","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1200\/JCO.20.00803","article-title":"Avelumab in patients with gestational trophoblastic tumors with resistance to single-agent chemotherapy: cohort a of the TROPHIMMUN phase II trial","volume":"38","author":"You","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.12.009_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2018.11.015","article-title":"Management and prognostic factors of epithelioid trophoblastic tumors: results from the International Society for the Study of trophoblastic diseases database","volume":"152","author":"Frijstein","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2024.12.009_bb0190","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/PGP.0000000000000876","article-title":"Dataset for the reporting of gestational trophoblastic neoplasia: recommendations from the international collaboration on Cancer reporting (ICCR)","volume":"41","author":"Hui","year":"2022","journal-title":"Int. J. Gynecol. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824012277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824012277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T01:17:31Z","timestamp":1738718251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824012277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"alternative-id":["S0090825824012277"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.12.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}